We are live on ! Find out more
HCC

Hirtle Callaghan & Co Portfolio holdings

AUM $2.92B
1-Year Est. Return 17.65%
This Fund
S&P 500
This Quarter Est. Return
+3.94%
1 Year Est. Return
+17.65%
3 Year Est. Return
+46.66%
5 Year Est. Return
+38.61%
10 Year Est. Return
+120.72%
AUM
$720M
AUM Growth
+$115M
Cap. Flow
+$87.4M
Cap. Flow %
12.13%
Top 10 Hldgs %
49.83%
Holding
741
New
103
Increased
58
Reduced
70
Closed
92

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$4.25M
2
SEIC icon
SEI Investments
SEIC
+$3.29M
3
IBM icon
IBM
IBM
+$2.77M
4
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$1.3M
5
APD icon
Air Products & Chemicals
APD
+$1.07M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$26M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$6.61M
3
KMP
KINDER MORGAN ENER PNTRS L.P.
KMP
+$3.47M
4
PRF icon
Invesco FTSE RAFI US 1000 ETF
PRF
+$2.96M
5
OKS
Oneok Partners LP
OKS
+$2.04M

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.48%
2 Financials 7.1%
3 Energy 5.05%
4 Technology 4.9%
5 Healthcare 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTN
251
DELISTED
Raytheon Company
RTN
$74K 0.01%
800
– –
HSP
252
DELISTED
HOSPIRA INC
HSP
$74K 0.01%
1,443
– –
NWSA icon
253
News Corp Class A
NWSA
$14.5B
$73K 0.01%
4,080
– –
KMR
254
DELISTED
KINDER MORGAN MANAGEMENT LLC
KMR
$72K 0.01%
945
– –
CIM
255
Chimera Investment
CIM
$1.05B
$71K 0.01%
1,433
– –
TEVA icon
256
Teva Pharmaceuticals
TEVA
$35.9B
$70K 0.01%
1,339
– –
WTRG icon
257
Essential Utilities
WTRG
$11.2B
$70K 0.01%
2,685
-1
-0% -$25
NS
258
DELISTED
NuStar Energy L.P.
NS
$70K 0.01%
1,121
– –
STJ
259
DELISTED
St Jude Medical
STJ
$70K 0.01%
1,001
– –
PRGS icon
260
Progress Software
PRGS
$1.55B
$65K 0.01%
2,700
– –
WRI
261
DELISTED
Weingarten Realty Investors
WRI
$64K 0.01%
+1,950
New +$61.3K
BCR
262
DELISTED
CR Bard Inc.
BCR
$64K 0.01%
450
-800
-64% -$114K
TWTR
263
DELISTED
Twitter, Inc.
TWTR
$62K 0.01%
1,520
+20
+1% +$757
ALTR
264
DELISTED
Altera Corp
ALTR
$61K 0.01%
+1,750
New +$59.1K
ADM icon
265
Archer Daniels Midland
ADM
$41.4B
$59K 0.01%
1,332
– –
HES
266
DELISTED
Hess
HES
$58K 0.01%
582
-250
-30% -$22.6K
MNK
267
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$57K 0.01%
+712
New +$51.6K
GSK icon
268
GSK
GSK
$103B
$56K 0.01%
823
– –
DNB
269
DELISTED
Dun & Bradstreet
DNB
$55K 0.01%
502
– –
ARCC icon
270
Ares Capital
ARCC
$13.5B
$54K 0.01%
2,939
+68
+2% +$1.17K
K
271
DELISTED
Kellanova
K
$54K 0.01%
872
– –
CPB icon
272
Campbell Soup
CPB
$6.51B
$53K 0.01%
1,155
– –
ACHN
273
DELISTED
Achillion Pharmaceuticals
ACHN
$53K 0.01%
7,000
-15,000
-68% -$59.9K
LMT icon
274
Lockheed Martin
LMT
$134B
$52K 0.01%
322
-250
-44% -$40.6K
MAR icon
275
Marriott International
MAR
$98.7B
$52K 0.01%
807
– –
9 10
11
12 13

Similar funds

CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
SCM
Steadfast Capital Management New York $2.92B AUM 26.34% 1-Year Est. Return
MYLI
Meiji Yasuda Life Insurance Tokyo, Japan $2.93B AUM 4.27% 1-Year Est. Return
CCM
CloudAlpha Capital Management Hong Kong $2.93B AUM 345.92% 1-Year Est. Return
BAM
BCV Asset Management Winnipeg $2.91B AUM
CWM
Calamos Wealth Management Naperville, Illinois $2.91B AUM 25.59% 1-Year Est. Return
NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
FNT
First National Trust Hermitage, Pennsylvania $2.93B AUM 22.18% 1-Year Est. Return

Hirtle Callaghan & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Hirtle Callaghan & Co held 741 positions worth $720M, up 19% from $605M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Hirtle Callaghan & Co deployed $87.4M of net new capital in Q2 2014, opening 103 new positions and adding to 58 existing holdings. Its largest new stake was Goldman Sachs: 26,355 shares worth $4.41M.

By sector, the portfolio is most concentrated in Consumer Staples at 21% of assets, down from 24% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Teledyne Technologies, an estimated $1M trimmed.

  • Hirtle Callaghan & Co's largest Q2 2014 buy was Goldman Sachs: 26,355 shares worth $4.41M.
  • Hirtle Callaghan & Co added most to iShares Russell Mid-Cap ETF in Q2 2014, an estimated $516K increase.
  • Hirtle Callaghan & Co's biggest Q2 2014 reduction was Teledyne Technologies, cutting an estimated $1M.
  • Hirtle Callaghan & Co fully exited iShares MSCI EAFE ETF in Q2 2014, selling an estimated $26M.
  • Hirtle Callaghan & Co's ten largest holdings make up 50% of its $720M portfolio in Q2 2014.
  • Hirtle Callaghan & Co opened 103 new positions and closed 92 in Q2 2014.
  • Hirtle Callaghan & Co's portfolio value rose 19% quarter-over-quarter to $720M.

Based on Hirtle Callaghan & Co's 13F filing for Q2 2014, filed 18 Jul 2014.